BCM
INAB icon

BIOS Capital Management’s IN8bio INAB Stock Holding History

BIOS Capital Management’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$248K Sell
167,805
-85,612
-34% -$166K 0.47% 6
2025
Q4 		$593K Sell
253,417
-33,247
-12% -$63.2K 0.72% 6
2025
Q3 		$622K Hold
286,664
– – 0.7% 6
2025
Q2 		$599K Sell
286,664
-3
-0% -$12 0.83% 6
2025
Q1 		$1.43M Hold
286,667
– – 1.8% 5
2024
Q4 		$2.21M Buy
+286,667
New +$2.52M 2.35% 5

Other funds holding INAB

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return

BIOS Capital Management's INAB Position: Q1 2026 in Review

BIOS Capital Management reduced its IN8bio (INAB) stake by 34% in Q1 2026, selling an estimated $166K and leaving 167,805 shares worth $248K. The position accounts for 0.47% of the portfolio, ranked #6.

BIOS Capital Management first reported a position in INAB in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.21M in Q4 2024. 19 funds tracked by Wall St. Rank hold INAB as of Q1 2026.

  • BIOS Capital Management held 167,805 shares of IN8bio worth $248K as of Q1 2026.
  • BIOS Capital Management sold 85,612 IN8bio shares in Q1 2026, an estimated $166K.
  • IN8bio made up 0.47% of BIOS Capital Management's portfolio in Q1 2026, its #6 holding.
  • BIOS Capital Management first reported a position in IN8bio in Q4 2024 and has held it in 6 quarters since.
  • BIOS Capital Management's IN8bio position peaked at $2.21M in Q4 2024.
  • 19 funds tracked by Wall St. Rank held IN8bio as of Q1 2026.

Based on BIOS Capital Management's 13F filing for Q1 2026, filed 13 May 2026.